(LHYFE) Lhyfe - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0014009YQ1

LHYFE: Renewable Energy, Green Hydrogen, Production Units

Lhyfe SA, a French renewable energy innovator, pioneers the development, installation, and operation of green hydrogen production facilities. Specializing in electrolysis technology, the company leverages renewable energy sources to produce zero-emission hydrogen, addressing the growing demand for decarbonized energy solutions. Lhyfe SA has established a robust portfolio of 93 projects across France, catering to a diverse range of sectors including local authorities, industrial complexes, transport networks, and fuel distribution hubs. Founded in 2017 and headquartered in Nantes, France, the company is at the forefront of the green hydrogen revolution, playing a critical role in the transition to sustainable energy systems.

From a technical perspective, Lhyfe SAs stock (Ticker: LHYFE) on the Paris Stock Exchange (PA) exhibits a 20-day average volume of 13,918 shares, with a last price of €3.42. The stocks moving averages indicate a recent price of €3.43 over 20 days, €3.27 over 50 days, and €3.60 over 200 days, suggesting a recent decline below the longer-term average. The Average True Range (ATR) of €0.14 reflects moderate volatility.

On the fundamental side, Lhyfe SA boasts a market capitalization of €163.40 million, with a price-to-book (P/B) ratio of 1.93, indicating that investors value the company slightly above its book value. However, the price-to-sales (P/S) ratio of 62.80 highlights a premium valuation relative to its revenue. The company currently reports a negative return on equity (RoE) of -54.71%, reflecting the early-stage nature of its operations and investments in growth.

Based on the convergence of and , Lhyfe SAs stock is expected to remain under pressure in the next 3 months. The recent decline below the 200-day moving average (SMA 200: 3.60) and the bearish crossover of the SMA 20 (3.43) below the SMA 50 (3.27) signal near-term weakness. The ATR of 0.14 suggests limited upside potential, with resistance likely at €3.50 and support at €3.20. Additionally, the high P/S ratio of 62.80 and negative RoE of -54.71% may deter value-oriented investors, further weighing on the stock price.

Additional Sources for LHYFE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

LHYFE Stock Overview

Market Cap in USD 169m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

LHYFE Stock Ratings

Growth Rating -68.8
Fundamental -
Dividend Rating 0.0
Rel. Strength 4.55
Analysts -
Fair Price Momentum 3.33 EUR
Fair Price DCF -

LHYFE Dividends

No Dividends Paid

LHYFE Growth Ratios

Growth Correlation 3m -38.6%
Growth Correlation 12m -85.1%
Growth Correlation 5y -93.3%
CAGR 5y -22.36%
CAGR/Max DD 5y -0.30
Sharpe Ratio 12m -0.08
Alpha -7.24
Beta 0.076
Volatility 46.89%
Current Volume 158.4k
Average Volume 20d 15.3k
What is the price of LHYFE stocks?
As of April 19, 2025, the stock is trading at EUR 4.10 with a total of 158,393 shares traded.
Over the past week, the price has changed by +27.53%, over one month by +26.74%, over three months by +30.99% and over the past year by -3.30%.
Is Lhyfe a good stock to buy?
No, based on ValueRay Analyses, Lhyfe (PA:LHYFE) is currently (April 2025) a stock to sell. It has a ValueRay Growth Rating of -68.81 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LHYFE as of April 2025 is 3.33. This means that LHYFE is currently overvalued and has a potential downside of -18.78%.
Is LHYFE a buy, sell or hold?
Lhyfe has no consensus analysts rating.
What are the forecast for LHYFE stock price target?
According to ValueRays Forecast Model, LHYFE Lhyfe will be worth about 3.7 in April 2026. The stock is currently trading at 4.10. This means that the stock has a potential downside of -10.49%.
Issuer Forecast Upside
Wallstreet Target Price 5.1 23.9%
Analysts Target Price - -
ValueRay Target Price 3.7 -10.5%